AXN-1901

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameAXN-1901
Drug Alias NameAXN-1901
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNAD-dependent deacetylase sirtuin 1 activators
TargetsNAD-dependent deacetylase sirtuin 1
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAxceso Biopharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAxceso Biopharma Co Ltd
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A